Your browser doesn't support javascript.
loading
Before, during, and after: An Argument for Safety and Improved Outcome of Thrombolysis in Acute Ischemic Stroke with Direct Oral Anticoagulant Treatment.
Monjazeb, Sanaz; Chang, Heather V; Lyden, Patrick D.
Affiliation
  • Monjazeb S; Department of Neurology, Zilkha Neurogenetic Institute of the Keck School of Medicine, Los Angeles, CA, USA.
  • Chang HV; Department of Physiology and Neuroscience, Zilkha Neurogenetic Institute of the Keck School of Medicine, Los Angeles, CA, USA.
  • Lyden PD; Department of Neurology, Zilkha Neurogenetic Institute of the Keck School of Medicine, Los Angeles, CA, USA.
Ann Neurol ; 2024 Sep 11.
Article de En | MEDLINE | ID: mdl-39258443
ABSTRACT
Direct oral anticoagulants are the primary stroke prevention option in patients with atrial fibrillation. Anticoagulant use before stroke, however, might inhibit clinician comfort with thrombolysis if a stroke does occur. Resuming anticoagulants after ischemic stroke is also problematic for fear of hemorrhage. We describe extensive literature showing that thrombolysis is safe after stroke with direct anticoagulant use. Early reinstitution of direct anticoagulant treatment is associated with lower risk of embolic recurrence and lower hemorrhage risk. The use of direct anticoagulants before, during, and after thrombolysis appears to be safe and is likely to promote improved outcomes after ischemic stroke. ANN NEUROL 2024.

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Ann Neurol / Ann. neurol / Annals of neurology Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Ann Neurol / Ann. neurol / Annals of neurology Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique